There were no significant differences in age, gender, smoking status, or TNM staging between the two groups; however, the patients with high S100A7 expression had more advanced tumor differentiation than those with low S100A7 expression (P = .001, Table 1). This evidence concerns the gene S100A7 and neoplasm.